Title |
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies
|
---|---|
Published in |
Psychopharmacology, November 2006
|
DOI | 10.1007/s00213-006-0621-y |
Pubmed ID | |
Authors |
Arlene D. Stark, Shaun Jordan, Kelly A. Allers, Robert L. Bertekap, Ruoyan Chen, Tanaz Mistry Kannan, Thaddeus F. Molski, Frank D. Yocca, Trevor Sharp, Tetsuro Kikuchi, Kevin D. Burris |
Abstract |
Aripiprazole (7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2(1H)-quinolinone) is a novel antipsychotic with a mechanism of action that differs from current typical and atypical antipsychotics. Aripiprazole interacts with a range of receptors, including serotonin [5-hydroxytryptamine (5-HT)] and dopamine receptors. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 2% |
United States | 1 | 2% |
Unknown | 60 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 23% |
Student > Ph. D. Student | 11 | 18% |
Student > Master | 8 | 13% |
Student > Bachelor | 6 | 10% |
Professor > Associate Professor | 6 | 10% |
Other | 9 | 15% |
Unknown | 8 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 26% |
Neuroscience | 14 | 23% |
Agricultural and Biological Sciences | 11 | 18% |
Psychology | 4 | 6% |
Biochemistry, Genetics and Molecular Biology | 3 | 5% |
Other | 7 | 11% |
Unknown | 7 | 11% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2023.
All research outputs
#4,596,403
of 22,774,233 outputs
Outputs from Psychopharmacology
#1,202
of 5,342 outputs
Outputs of similar age
#20,156
of 155,426 outputs
Outputs of similar age from Psychopharmacology
#8
of 28 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,342 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,426 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.